Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02614261
Brief Title: Evaluation of Galcanezumab in the Prevention of Chronic Migraine (REGAIN)

First Submitted : November 23, 2015
First Submitted that Met QC Criteria : November 23, 2015
First Posted : November 25, 2015 (Estimate)

Results First Submitted : October 19, 2018
Results First Submitted that Met QC Criteria : December 12, 2018
Results First Posted : January 7, 2019

Certification/Extension First Submitted : March 15, 2018
Certification/Extension First Submitted that Met QC Criteria : March 15, 2018
Certification/Extension First Posted : March 19, 2018

Last Update Submitted that Met QC Criteria : June 8, 2020
Last Update Posted : June 22, 2020